Atlas Trials

Inge Marie Svane

25 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Inge Marie Svane

RecordFirmDate
Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events (NCT07694414)Inge Marie Svane2026-08-01
Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma (NCT07501117)Inge Marie Svane2026-06-29
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma (NCT06204991)Inge Marie Svane2025-04-01
T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma (NCT06783270)Inge Marie Svane2024-12-16
ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma (NCT04904185)Inge Marie Svane2021-09-17
T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer (NCT04611126)Inge Marie Svane2021-04-22
Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis (NCT04810156)Inge Marie Svane2021-04-07
Dual Vaccine Trial in Myeloproliferative Neoplasms (NCT04051307)Inge Marie Svane2019-07-10
Melanoma Metastasized to the Brain and Steroids (NCT03563729)Inge Marie Svane2018-06-06
Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma (NCT03047928)Inge Marie Svane2018-02-22
Adoptive Cell Therapy Across Cancer Diagnoses (NCT03296137)Inge Marie Svane2017-10-13
TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer (NCT03287674)Inge Marie Svane2017-10-09

Track Inge Marie Svane automatically

Every clearance here is in the API, with alerts when new ones post.